Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers
Titel:
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers
Auteur:
Ramanathan, Ramesh K. Fakih, Marwan Mani, Sridhar Deutsch, Melvin Perez, Raymond P. Ritter, Mark A. Eiseman, Julie L. Ivy, S. Percy Trump, Donald L. Belani, Chandra P. Parise, Robert A. Potter, Douglas M. Egorin, Merrill J.